US MedSys adds SofPulse to woundcare line:
This article was originally published in Clinica
Denver, Colorado-based US MedSys has entered into a marketing and distribution agreement with ADM Tronics' subsidiary, Ivivi Technologies, for the latter's SofPulse electrotherapy device. The noninvasive technology, designed to reduce pain and oedema in soft tissue, complements US MedSys's EpiScan I-200 ultrasound imaging system, which is used to scan and assess soft tissue to a depth of 3cm. The two devices will form an integral part of US Medsys's woundcare management programme for chronic wounds.
You may also be interested in...
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.